IQVIA

Informatore Scientifico del Farmaco (Genova)

Milan, Lombardy, Italy

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalsIndustries

Requirements

The candidate should possess a Bachelor's degree in scientific disciplines (Law 219/06), experience in promoting pharmaceuticals to General Practitioners or gastroenterologists, and at least six months of experience in the same role at a structured company. A proven track record of achieving individual goals is also required.

Responsibilities

The Informatore Scientifico del Farmaco (ISF) Freelance will manage and maintain relationships with MMG doctors in their area of expertise, collaborating with colleagues to achieve predefined objectives. They will also promote a launching drug and supplements within the target audience of general practitioners and gastroenterologists, reporting directly to the Area Manager.

Skills

Pharmaceutical Promotion
General Practitioners
Gastroenterologists
Relationship Management
Sales
Achieving Goals

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Key Metrics

Durham, North CarolinaHeadquarters
1998Year Founded
$3,526MTotal Funding
POST_IPO_EQUITYCompany Stage
Cybersecurity, Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.
Proliferation of disparate technological solutions causes technology overload in clinical trials.
Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.
The company offers privacy-enhancing technologies to protect individual patient data.
IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.
AI-driven drug discovery accelerates identification of potential drug candidates.
Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI